Enhancing oncology care: A prospective observational study on counseling practices of hospital pharmacists

Abstract

Introduction

Pharmacists are crucial in oncology and haematology, especially in medication management, patient counselling, and healthcare team collaboration. Their roles differ across institutions and countries. In Italy, where hospital pharmacies distribute oral cancer therapies, there is an emerging need for standardized counselling practices to enhance patient outcomes. This study aims to examine the current counselling practices of hospital pharmacists in Italy's oncology and haematology settings, identifying areas for improvement to better support patient care.

Method

A web-based questionnaire was used for this prospective observational study, distributed through a national oncology pharmacists’ network (Oncofarma). It was organized into three sections covering demographic information, counselling activities for patients and physicians, and communication methods. Data were analysed descriptively, with participants recruited through convenience sampling.

Results

Of the 99 participants from 61 centres surveyed, most were NHS hospital pharmacists. Half provided advice to oncologists or haematologists, and 36% engaged in direct patient counselling. Pharmacists typically advised on drug administration, side effects, and drug interactions, with communication primarily through face-to-face interactions or telephone calls. Counselling often took place at pharmacy counters or on hospital wards, with limited access to dedicated consultation spaces or times.

Conclusion

The study reveals variability in Italian hospital pharmacists’ counselling practices in oncology and haematology. Expanding patient counselling and introducing structured communication protocols may improve care quality. Standardised guidelines and training in communication, clinical knowledge and documentation could improve consistency, improve patient outcomes and support the integration of pharmacists into the healthcare team.